Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enterovirus A71 RNA-dependent RNA polymerase (3Dpol) is the core catalytic enzyme responsible for the replication and transcription of the viral positive-sense single-stranded RNA genome [1, 5]. It functions by synthesizing a negative-strand RNA intermediate from the genomic template, which then serves as a template for the production of progeny positive-strand RNAs [5, 12]. Additionally, 3Dpol catalyzes the uridylylation of the viral protein VPg, a critical step that provides the primer necessary for initiating RNA synthesis [1, 12]. Beyond its enzymatic role, 3Dpol interacts with numerous host factors, such as ribosomal proteins and splicing factors, to hijack the cellular translation machinery and suppress host immune responses [1, 2, 12]. EV-A71 is a primary cause of hand, foot, and mouth disease (HFMD) and can lead to severe, life-threatening neurological conditions like brainstem encephalitis and acute flaccid paralysis [5, 11, 13]. Because 3Dpol is essential for viral survival and lacks a direct human homolog, it is considered a premier target for the development of direct-acting antivirals [6, 7, 11]. Therapeutic agents targeting this enzyme include nucleoside analogs that induce premature chain termination and non-nucleoside inhibitors that allosterically interfere with the polymerase's elongation activity [7, 10, 11]. Research into 3Dpol inhibitors is ongoing, with several compounds demonstrating potent activity in preclinical models, although the rapid emergence of resistant mutations remains a significant therapeutic challenge [7, 11].
Inhibition of viral RNA synthesis through chain termination or allosteric inhibition of the polymerase elongation activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Enterovirus A71 RNA-dependent RNA polymerase (3Dpol) (3Dpol).